Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€72.60
28.06.21
€120.00
28.06.22
-21.07%
12.07.21

Could be worthwhile Investment >10% per year
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€146.55
28.06.21
€200.00
28.06.22
-3.62%
12.07.21

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€48.00
28.06.21
€75.00
28.06.22
-2.98%
12.07.21

Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
buy
Buzzi Unicem SpA

Start price
Target price
Perf. (%)
€22.75
27.06.21
€25.00
27.06.22
-13.49%
28.09.21

Could be worthwhile Investment >10% per year
buy
Banco Comercial Portugues

Start price
Target price
Perf. (%)
€0.14
27.06.21
€0.22
27.06.22
21.22%
28.06.22

Could be worthwhile Investment >10% per year
buy
The Navigator Company S.A.

Start price
Target price
Perf. (%)
€2.91
27.06.21
€3.20
27.06.22
32.21%
28.06.22

Could be worthwhile Investment >10% per year
buy
Financiere Odet

Start price
Target price
Perf. (%)
€1,180.0
27.06.21
€120.00
27.06.22
11.86%
05.11.21

Could be worthwhile Investment >10% per year
buy
thyssenkrupp AG

Start price
Target price
Perf. (%)
€8.98
27.06.21
€12.00
27.06.22
-33.17%
27.06.22

Could be worthwhile Investment >10% per year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€192.00
25.06.21
-
25.06.22
24.64%
23.07.21

Could be worthwhile Investment >10% per year
buy
Evonik Industries AG

Start price
Target price
Perf. (%)
€28.17
24.06.21
-
24.06.22
-22.97%
25.06.22

Vicat S.A.

Start price
Target price
Perf. (%)
€30.80
21.06.21
€39.00
-
21.06.21

Could be worthwhile Investment >10% per year
buy
Evotec SE

Start price
Target price
Perf. (%)
€37.08
21.06.21
-
21.06.22
4.91%
29.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€39.90
21.06.21
-
21.06.22
19.05%
27.08.21

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Little Investments for future growth
buy
Varta AG

Start price
Target price
Perf. (%)
€130.55
21.06.21
-
21.06.22
1.07%
30.08.21

buy
Varta AG

Start price
Target price
Perf. (%)
€129.50
21.06.21
€145.00
21.06.22
3.82%
29.06.21

Standard Investments for future growth
Known brand
Future proof or reliable business model
Higher risks for its business
Rational AG

Start price
Target price
Perf. (%)
€732.00
20.06.21
€700.00
20.06.22
-23.43%
21.06.22

Could be worthwhile Investment >10% per year
buy
Mediaset Espana

Start price
Target price
Perf. (%)
€4.84
19.06.21
€6.00
19.06.22
-22.69%
20.06.22

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.92
19.06.21
€58.00
19.06.22
-20.72%
27.12.21

Could be worthwhile Investment >10% per year
buy
Cnova NV

Start price
Target price
Perf. (%)
€10.45
19.06.21
€12.50
19.06.22
-53.59%
20.06.22

Could be worthwhile Investment >10% per year
buy
Sofina

Start price
Target price
Perf. (%)
€360.00
19.06.21
€378.00
19.06.22
-43.94%
20.06.22

Could be worthwhile Investment >10% per year
buy
Solaredge Technologies Inc

Start price
Target price
Perf. (%)
€219.00
18.06.21
€325.00
18.06.22
20.84%
18.06.22

Could be worthwhile Investment >10% per year
Sustainability is very important
Innovative
Some uniques
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€413.70
18.06.21
€600.00
18.06.22
35.75%
27.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
buy
Brenntag SE

Start price
Target price
Perf. (%)
€77.58
18.06.21
€90.00
18.06.22
-12.61%
18.06.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Standard Investments for future growth
Valuable balance sheet
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€46.95
16.06.21
€75.00
16.06.22
2.24%
28.06.21

Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
buy
Wendel S.A.

Start price
Target price
Perf. (%)
€117.10
14.06.21
€118.00
14.06.22
-26.30%
15.06.22

Could be worthwhile Investment >10% per year